Cold Spring Harbor Laboratory rolls out STEM ‘Bicycle Principles’

Success in science, technology, engineering, and mathematics (STEM) demands keeping up with the latest tools and techniques. The AI boom, for example, has made coding and data management skills integral. But going back to school isn’t an option for most scientists. Short training programs like webinars and boot camps have become a popular alternative among busy STEM professionals. However, these formats can have significant shortcomings. There’s often no guarantee attendees will leave with the skills needed to advance their careers. And they can be exclusionary, preventing learners of all abilities and circumstances from benefiting equally.

We’ve all had horrible teachers,” recalls Jason Williams. Williams is Assistant Director of Diversity and Research Readiness at the Cold Spring Harbor Laboratory (CSHL) DNA Learning Center. “There have been efforts to improve science education at the undergraduate level for decades. But there’s basically no effort to improve education once you’ve graduated. It’s just assumed you’ll somehow keep up.”

To tackle this problem, Williams and collaborators have created a new teaching framework called the “Bicycle Principles.” It aims to make short STEM training effective, inclusive, and scalable. The principles originated from a meeting at CSHL’s Banbury Center think tank. Williams and co-organizer Rochelle Tractenberg recruited the world’s leading experts in short-format education. They identified the field’s biggest issues and ways to address them.

The group came up with two sets of principles linked like bicycle wheels. One wheel, Core Principles, focuses on effectiveness and inclusivity. Recommendations here include setting clear objectives participants of all abilities can achieve. The other wheel, Community Principles, revolves around reach, accessibility, and sustainability. It recommends making training adaptable for different institutions, especially those lacking the resources of large universities.

Williams says the Banbury meeting and the guidelines it inspired are the first of their kind. He hopes they won’t be the last. Williams explains:

“If we can raise awareness, we can start doing something about it. Our goal was to put the first flag in the ground to say, ‘Here are the key problems scientists face in professional development. And here are some potential solutions.'”

Such improvements could help researchers achieve their career goals and increase the impact of their work—familiar objectives for Williams and CSHL. The institution supports a number of science career paths through its education initiatives. These begin as early as grade school via the DNA Learning Center. And they continue throughout a scientist’s career, with CSHL’s Meetings & Courses Program.

After all, learning is a journey. The Bicycle Principles can make the trip more successful for all.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Unlike classical mass photometry technology, KaritroMP utilizes light scattering to measure both the size and contrast of single particles, allowing for large particles such as AdVs and LVVs to be characterized across two dimensions.
Research liquids are the key accessories for various research processes, and Lotilabs offers the best quality research liquids.
Asep Medical Holdings received confirmation from its attorneys of its US Patent Application No. 16/279788, which has been subsequently validated in the US, representing 332 million people. This patent is in addition to the successful European and Australian patents awarded to the Company in November of 2022, which represent approximately 400 million people.
“By harnessing the power of AI models and algorithms, with our unique data and experiments, we're unlocking scientific discoveries with incredible speed and generating insights at an unprecedented scale,” said Aviv Regev, EVP and head of Genentech Research and Early Development (gRED). “Bringing science and technology together has always been a foundation of biomedical breakthroughs at Genentech. We are thrilled to join forces with NVIDIA to further optimize our drug discovery and development to deliver treatments that transform people’s lives.”
"The assumption that we each have a single genome turns out to be off by a trillion-fold," said Geoffrey von Maltzahn, Ph.D., Co-Founder and Chief Executive Officer of Quotient Therapeutics and General Partner, Flagship Pioneering. "All cells accumulate random genetic changes in their DNA, resulting in trillions of unique genomes in the body. Some genetic changes make a cell resistant or vulnerable to disease, while others can cause disease. We started Quotient to study the natural genetics library inside every tissue, discover gene variants that are beneficial, neutral, or disease-causing, and to harness that knowledge to develop the medicines of tomorrow."

By using this website you agree to accept Medical Device News Magazine Privacy Policy